Sec Form 4 Filing - Sanderling Venture Partners V, LP @ CHIMERIX INC - 2013-11-13

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Sanderling Venture Partners V, LP 2. Issuer Name and Ticker or Trading Symbol CHIMERIX INC [ CMRX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director X __ 10% Owner _____ Officer (give title below) _____ Other (specify below) (Last) (First) (Middle) 400 SOUTH EL CAMINO REAL, SUITE 1200 3. Date of Earliest Transaction (MM/DD/YY) 11/13/2013 (Street) SAN MATEO, CA94402 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) _____ Form filed by One Reporting Person __ X __ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 11/13/2013 J( 1 ) 94,633 D $ 0 4,161,193 I See Footnote ( 2 ) Common Stock 11/13/2013 J( 3 ) 7,543 D $ 0 4,153,650 I See Footnote ( 2 )

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Sanderling Venture Partners V, LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X SANDERLING V BIOMEDICAL LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X SANDERLING V LTD PARTNERSHIP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X SANDERLING V BETEILIGUNGS GMBH & CO KG 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X SANDERLING VENTURES MANAGEMENT V 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X SANDERLING V BIOMEDICAL CO INVESTMENT FUND LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X Sanderling Venture Partners V Co Investment Fund, LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X Sanderling V Strategic Exit Fund LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X Sanderling Venture Partners VI Co Investment Fund LP 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X Sanderling VI Beteiligungs GmbH & Co KG 400 SOUTH EL CAMINO REAL, SUITE 1200 SAN MATEO, CA94402 X Signatures See Signatures Included in Exhibit 99.2 11/15/2013 Signature of Reporting Person Date

Explanation of Responses:

( 1 )Pro rata distribution by Sanderling Ventures Management V to its Managing Directors. ( 2 )See attached Exhibit 99.1 ( 3 )Pro rata distribution by Sanderling Ventures Management VI to its Managing Directors.

Remarks: Form 4 filing 1 of 2. See Form 4 filing 2 of 2 for additional members of this joint filing.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.